NYBA
New York Biotechnology Association
 
 
More...
NYBA: Member News
Archived News | Press Release | NYBA News
 
 
 
ImClone Systems Incorporated
Headline: IMCLONE ANNOUNCES AGREEMENT WITH FDA ON SPECIAL PROTOCOL ASSESSMENT FOR PHASE III
STUDY OF IMC-1121B IN BREAST CANCER
Date: 22-Apr-2008
IMCLONE ANNOUNCES AGREEMENT WITH FDA ON SPECIAL PROTOCOL ASSESSMENT FOR PHASE III STUDY OF IMC-1121B IN BREAST CANCER NEW YORK--(BUSINESS WIRE)--April 22, 2008--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that it has reached agreement with the U.S. Food and Drug Adminis... .
Details »
 
 
Pfizer Inc.
Headline: Pfizer Japan To Launch Champix® The First Prescription Oral Smoking Cessation Aid In
Japan
Date: 22-Apr-2008
Pfizer Japan to Launch Champix® the First Prescription Oral Smoking Cessation Aid in Japan Inhibits A Sense Of Satisfaction Associated With Smoking And Relieves Tobacco Craving TOKYO--(BUSINESS WIRE)--Pfizer Inc announced today that on May 8, 2008, it will launch Champix® Tablet 0.5mg/1mg (varenicline tartrate), a novel smoking cessation aid for s... .
Details »
 
 
Pfizer Inc.
Headline: High-Dose Lipitor Reduced The Risk Of Heart Attack And Stroke In Patients With
Chronic Kidney Disease
Date: 21-Apr-2008
High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in Patients with Chronic Kidney Disease NEW YORK--(BUSINESS WIRE)-- Pfizer Inc announced today that Lipitor® (atorvastatin calcium) 80 mg reduced the risk of heart attack and stroke by 32 percent in patients who have heart disease and chronic kidney disease compared with patients taking the... .
Details »
 
 
Pfizer Inc.
Headline: Pfizer Japan Receives Manufacturing And Marketing Authorization For SUTENT
Date: 21-Apr-2008
Pfizer Japan Receives Manufacturing and Marketing Authorization for SUTENT For the Treatment of Two Difficult-to-Treat Advanced Cancers TOKYO--(BUSINESS WIRE)--Pfizer Japan Inc announced that on April 16, the company received an approval for the manufacturing and marketing authorization of the anti-tumor drug/kinase inhibitor “SUTENT® Capsule 12... .
Details »
 
 
Genentech Inc.
Headline: Genentech Provides Update On "AVAiL" Phase III Study Of Avastin Plus Chemotherapy In
First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer
Date: 20-Apr-2008
Genentech Provides Update on "AVAiL" Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer South San Francisco, Calif. --  April 20, 2008 --  Genentech, Inc. (NYSE: DNA) today announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin® (b... .
Details »
 
 
SIGA Technologies, Inc.
Headline: Dr. Dennis E. Hruby, Chief Science Officer Of SIGA Technologies, To Present CDC
Distinguished Lecture On Smallpox Antiviral Drug ST-246
Date: 18-Apr-2008
NEW YORK, Apr 18, 2008 (BUSINESS WIRE) -- SIGA Technologies, Inc., a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, announced today that its Chief Scientific Officer, Dr. Dennis E. Hruby, is presenting a Distinguished Lecture at the Centers for Disease Control and Prevention (CDC) in Atlanta on Wednesday, April 23, 2008. Dr. Hruby's presentation... .
Details »
 
 
Pfizer Inc.
Headline: Pfizer Opens New Development Centre
Date: 18-Apr-2008
Pfizer Opens New Development Centre BRUSSELS, Belgium--(BUSINESS WIRE)--A new development centre for veterinary vaccines which will accelerate the development of new animal health products has been opened by Pfizer as part of its annual $300 million (US dollar) commitment to research and development. The new centre is located on the Louvain-la-Neuve scien... .
Details »
 
 
Pfizer Inc.
Headline: Federal Court In Canada Upholds Pfizer’s Norvasc Patent;
Date: 17-Apr-2008
Federal Court in Canada Upholds Pfizer’s Norvasc Patent; Decision Prevents Launch of Generic Amlodipine Besylate Product by Pharmascience until 2010 NEW YORK--(BUSINESS WIRE)--Pfizer Inc said today that the Canadian Federal Court has upheld a Pfizer patent covering amlodipine besylate, the active ingredient in Norvasc. The court issued an order prohibiting r... .
Details »
 
 
Pfizer Inc.
Headline: Lyrica Reduced Pain Of Fibromyalgia In Patients Regardless Of Symptoms Of Anxiety Or
Depression
Date: 16-Apr-2008
Lyrica Reduced Pain of Fibromyalgia in Patients Regardless of Symptoms of Anxiety or Depression Patient Reports of Improvement Linked to Reduction in Pain and Enhanced Sleep CHICAGO--(BUSINESS WIRE)--Pfizer’s Lyrica reduced pain of fibromyalgia in patients regardless of whether they experienced symptoms of anxiety or depression at the beginning of t... .
Details »
 
 
Chembio Diagnostic Systems Inc.
Headline: Chembio Signs Exclusive DPP(TM) Development Agreement With Bio-Rad
Date: 16-Apr-2008
Chembio Signs Exclusive DPP(TM) Development Agreement With Bio-Rad Laboratories, Inc. MEDFORD, NY, Apr 16, 2008 (MARKET WIRE via COMTEX News Network) -- Chembio Diagnostics, Inc. (OTC BB: CEMI) ("Chembio" or the "Company") announced today that it has signed an exclusive development agreement with Bio-Rad Laboratories, Inc. ("Bio-Rad") (AMEX: BIO) an... .
Details »
 
   
  © 2007 New York Biotechnology Association HOME | ABOUT NYBA | CONTACT US | SITE MAP Website by Axxiem